Interpreting Lipid Profiles for Cardiovascular Risk Assessment
Components of a Lipid Profile
- A standard lipid profile includes total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides, according to the American College of Cardiology 3
- Non-HDL cholesterol, calculated as total cholesterol minus HDL-C, is an important additional parameter that captures all atherogenic lipoproteins, as recommended by the American College of Cardiology 2
Collection and Measurement Considerations
- Either fasting or non-fasting samples can be used for initial lipid assessment and cardiovascular risk estimation in adults, as stated by the American College of Cardiology 3
- If initial non-fasting triglyceride levels are elevated, a repeat fasting lipid profile should be obtained, according to the American College of Cardiology 3
- For LDL-C levels <70 mg/dL, direct LDL-C measurement or modified calculation methods are recommended for improved accuracy over the standard Friedewald formula, as suggested by the American College of Cardiology 3
Risk Assessment Framework
- Lipid parameters should be interpreted in the context of overall cardiovascular risk, considering factors such as family history of premature cardiovascular disease, as recommended by the European Society of Cardiology and the American Heart Association 4, 1
- Risk categories include very high risk, high risk, moderate risk, and low risk, with corresponding LDL-C goals, as defined by the European Society of Cardiology 4
Interpretation of Lipid Parameters
LDL-C
- The American College of Cardiology recommends LDL-C as the primary target for cardiovascular risk assessment and treatment decisions, with goals of <70 mg/dL for very high-risk adults, <100 mg/dL for high-risk adults, <130 mg/dL for moderate-risk adults, and <160 mg/dL for low-risk adults 1, 3
Triglycerides
- The American Heart Association defines normal triglyceride levels as <150 mg/dL, borderline high as 150-199 mg/dL, high as 200-499 mg/dL, and very high as ≥500 mg/dL, which is a risk factor for pancreatitis 1, 5
Non-HDL Cholesterol
- The American College of Cardiology recommends non-HDL cholesterol as a secondary target after LDL-C, with goals typically 30 mg/dL higher than LDL-C goals 1, 3
Special Populations
Children and Adolescents
- The American Academy of Pediatrics recommends universal lipid screening at ages 9-11 years, and selective screening for children 2-8 years with risk factors, with interpretation of LDL-C levels as acceptable (<110 mg/dL), borderline (110-129 mg/dL), or high (≥130 mg/dL) 5, 7
- The American Academy of Pediatrics also recommends universal screening once between ages 17-21 years 5, 7